"The Emily Couric Clinical Cancer Center in Charlottesville, VA offers convenient access to a full range of state-of-the-art cancer treatments, all in a warm and inviting space."

During the past decade, University of Virginia - Emily Couric Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Virginia - Emily Couric Cancer Center" are "Essential Thrombocythemia" (1 trials), "Head and Neck Cancer" (1 trials), "Non Small Cell Lung Cancer Metastatic" (1 trials), "Platinum Resistant Ovarian Cancer" (1 trials) and "Polycythemia Vera" (1 trials). Many other conditions were trialed in "University of Virginia - Emily Couric Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Virginia - Emily Couric Cancer Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Ropeginterferon alfa-2b-njft (P1101)" (2 trials), "INCAGN02385" (1 trials), "INCAGN02390" (1 trials), "P1101 (Ropeginterferon alfa-2b-njft)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Virginia - Emily Couric Cancer Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "University of Virginia - Emily Couric Cancer Center". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University of Virginia - Emily Couric Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Virginia - Emily Couric Cancer Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".